Myelodysplastic Syndromes (MDS) are a group of disorders characterized by the abnormal growth of blood cells within the bone marrow. As an expert in the field of hematology, I can provide you with an informed perspective on the potential outcomes of MDS. MDS can indeed lead to death, but the risk varies depending on the specific type and severity of the condition. The primary causes of death in MDS patients are complications related to the underlying disease. These include: 1. Bleeding: MDS can result in a low platelet count, which increases the risk of spontaneous bleeding that can be life-threatening. 2. Infection: A low white blood cell count can leave patients more susceptible to infections, which can be severe or even fatal. 3. Transformation to Acute Myeloid Leukemia (AML): MDS can progress to AML, which is a more aggressive form of cancer and has a higher risk of mortality. It is important to note that while about a third of patients with MDS may develop AML, not all MDS cases are fatal, and the prognosis can vary widely. Treatment options, the patient's age, overall health, and the specific characteristics of their MDS can significantly influence the outcome. read more >>

ON THIS PAGE: You will find information about the number of people who diagnosed with MDS each year. ... Death from MDS is often caused by bleeding and/or infection from low blood cell counts or after the disease becomes acute myeloid leukemia (AML). About a third of patients with MDS develop AML.read more >>